The 4 Best Dow Performers This Week
4) The Coca-Cola Company (NYSE:KO)
Coca-Cola has been a favorite pick among dividend hunters for a long time. The company behind the world’s most-popular soda and most-valuable brand favors its investors with a 2.60 percent dividend yield, and the stock is about as stable as they come with a beta of 0.36, meaning it is far less volatile than the market at large.
Coca-Cola is due to release its earnings on Tuesday before the markets open, and the company is expected to post another respectable quarter of growth. Analysts are looking for non-GAAP earnings of $0.44 per share on revenue of $11.54 billion.
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012*|
|Revenue ($) in millions||11,040||11,140||13,080||12,340||11.54|
|Diluted EPS ($)||0.355||0.445||0.605||0.50||0.44|
Signs of weakness in the overall soft-drink market in North America have had some analysts downwardly revising their estimates, this shift in consumption is not catching Coca-Cola off guard. Shares increased 3.14 percent for the week in anticipation of the earnings.
3) Hewlett-Packard Company (NYSE:HPQ)
Shares of this beleaguered but loved PC maker climbed 3.44 percent for the week. The company won’t report its earnings until February 21 after the markets close, and the expectations are for decreased earnings and revenue. Analysts are looking for non-GAAP earnings of $0.71 per share, a 22.82 percent year-over-year decline, and revenue of $27.77 billion, a 7.5 percent year-over-year decline.
|Quarter||Jan. 31, 2012||Apr. 30, 2012||Jul. 31, 2012||Oct. 31, 2012||Jan. 31, 2013*|
|Revenue ($) in millions||30,040||30,690||29,670||29,960||27.77|
|Diluted EPS ($)||0.73||0.80||-4.49||-3.45||0.71|
On the radar for HP last week is the announcement that Larry Stack, a managing direction of Global Sales chief at Accenture (NYSE:ACN), will come on board as HP’s new senior VP of Global Sales and Enterprise Services. This is not a small deal, given that HP’s Enterprise Sales unit was recently smacked with an $8 billion impairment charge related to a botched acquisition.
HP also weighed in on Dell’s (NASDAQ:DELL) leveraged buyout plan, stating: “Dell has a very tough road ahead. The company faces an extended period of uncertainty and transition that will not be good for its customers. And with a significant debt load, Dell’s ability to invest in new products and services will be extremely limited. Leveraged buyouts tend to leave existing customers and innovation at the curb. We believe Dell’s customers will now be eager to explore alternatives, and HP plans to take full advantage of that opportunity.”
2) American Express Company (NYSE:AXP)
American Express powered to weekly gains of 3.65 percent, simultaneously striking chords of optimism and concern. Shares of the credit company are up over 18 percent year over year, a laggard in a broad and tremendous credit-card company rally for the period, but a participant nonetheless.
Bears are concerned that the long run will soon lose its steam and with it, the market may find itself falling out of love with the stock. Quarterly revenue growth for the company is below its major competitors and insiders have been exiting their positions left and right recently. Here’s just a few:
|Relationship||Date||Transaction||Number of Shares||Value ($)|
|Chief Human Resources Officer||Feb. 04, 2013||Sale||16,325||969,145|
|EVP-Corp. Affairs||Feb. 04, 2013||Sale||69,958||4,145,566|
|Group Pres., Global Services||Feb. 04, 2013||Sale||50,031||3,512,156|
|EVP. Human Resources||Jan. 30, 2012||Sale||44,451||2,645,392|
|Group. Pres., Global Services||Jan. 30, 2012||Sale||28,977||1,716,308|
1) UnitedHealth Group Incorporated (NYSE:UNH)
UnitedHealth edged out American Express with 3.69 percent gains for the week. The health-services company has been riding high ever since it posted strong results on January 17, which revealed a fifth consecutive year of top- and bottom-line growth.
|Revenue ($) in millions||81,190||87,140||94,160||101,860||110,620|
It’s hard to ask for more than strong and consistent growth from one of the biggest health-care companies on the block.